Advertisement
AmBisome alone and combined with miltefosine for visceral leishmaniasis in HIV patients

January 17, 2019

AmBisome alone and combined with miltefosine for visceral leishmaniasis in HIV patients

Severine Blesson and colleagues report the results of a trial on the efficacy and safety of the internationally recommended treatment of AmBisome monotherapy and the new AmBisome-miltefosine combination regimen in Ethiopian patients.

Image credit: DNDI

NTD Modelling Consortium: Insights on data needs

Explore our collection on data collection and mathematical modelling in NTD epidemiology

Click Here

Recently Published Articles

Current Issue

Current Issue December 2018

01/17/2019

Review

Chikungunya as a paradigm for emerging viral diseases

Giovanni Rezza, Scott C. Weaver review recent findings regarding the need for a CHIKF vaccine and provide an update on vaccines nearing or having entered clinical trials. Read the Abstract.

Image credit: Le Goff, G., Brengues, C. & Robert, V., Wikimedia Commons

Chikungunya as a paradigm for emerging viral diseases

Get new content from PLOS Neglected Tropical Diseases in your inbox

Thank you! You have successfully subscribed to the PLOS Neglected Tropical Diseases newsletter.

Sorry, an error occurred while sending your subscription. Please try again later.

Try again